Sagent Pharmaceuticals Competitors and Similar CompaniesClear all
Sagent Pharmaceuticals's competitors and similar companies include Amneal Pharmaceuticals, Inogen, Globus Medical and Cochlear.
 Sagent Pharmaceuticals Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products. |  Amneal Pharmaceuticals Amneal Pharmaceuticals is a company that specializes in developing, manufacturing, and distributing of generic products which include complex dosage forms in a broad range of therapeutic areas. |  Globus Medical Globus Medical is the musculoskeletal implant manufacturer with a primary goal of improving the quality of life for patients with musculoskeletal disorders. | |||
Founding Date | Founding Date 2006 | Founding Date 2002 | Founding Date 2001 | Founding Date 2003 | Founding Date 1982 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Schaumburg, US HQ | Locations Bridgewater Township, US HQ Gröbenzell, DE Ahmedabad, IN Ahmedabad, IN Ahmedabad, IN Dahej, IN Mahabubnagar, IN see more | Locations Eagleville, US HQ | Locations Macquarie Park, AU HQ Wien, AT Mechelen, BE Toronto, CA Beijing, CN Prague, CZ Vantaa, FI see more | |
Employees | Employees 2261% increase | Employees 8,1005% increase | Employees 1,0207% decrease | Employees 2,00011% increase | Employees 4,996 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.6 b | Valuation ($) 222 m | Valuation ($) 10.1 b | Valuation ($) 13 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $318.3m (FY, 2015) | Revenue (est.) $3b (FY, 2025) | Revenue (est.) $348.7m (FY, 2025) | Revenue (est.) $2.9b (FY, 2025) | Revenue (est.) $2.4b (FY, 2025) |
Cost of goods | Cost of goods $230.6m (FY, 2015) | Cost of goods $1.9b (FY, 2025) | Cost of goods $163.8m (FY, 2025) | Cost of goods $957.8m (FY, 2025) | Cost of goods $524.8m (FY, 2025) |
Gross profit | Gross profit $87.7m (FY, 2015) | Gross profit $1.1b (FY, 2025) | Gross profit $154.3m (FY, 2025) | Gross profit $2b (FY, 2025) | Gross profit $1.9b (FY, 2025) |
Net income | Net income ($21.9m) (FY, 2015) | Net income $127.9m (FY, 2025) | Net income ($22.7m) (FY, 2025) | Net income $537.9m (FY, 2025) | Net income $388.9m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 70m | Total funding raised N/A | Total funding raised $ 29.6m | Total funding raised $ 110m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Amneal Pharmaceuticals
HQ
Bridgewater Township, US
Employees
8,100↑ 5% increase
Amneal Pharmaceuticals is a company that specializes in developing, manufacturing, and distributing of generic products which include complex dosage forms in a broad range of therapeutic areas.
View company
Inogen
HQ
Goleta, US
Employees
1,020↓ 7% decrease
Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy.
View companyGlobus Medical
HQ
Eagleville, US
Employees
2,000↑ 11% increase
Globus Medical is the musculoskeletal implant manufacturer with a primary goal of improving the quality of life for patients with musculoskeletal disorders.
View company
Cochlear
HQ
Macquarie Park, AU
Employees
4,996
Cochlear is a company developing implantable hearing solutions.
View company